BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.760
-0.260 (-12.87%)
Nov 12, 2025, 10:17 AM EST - Market open
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $34.58 million as of November 12, 2025. Its market cap has increased by 38.99% in one year.
Market Cap
34.58M
Enterprise Value
131.19M
1-Year Change
38.99%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $34.58M, a decrease of -79.96%. That is a compound annual growth rate of -18.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2025 | 39.69M | 113.87% |
| Dec 31, 2024 | 18.56M | -78.51% |
| Dec 29, 2023 | 86.35M | -85.65% |
| Dec 30, 2022 | 601.94M | 5.82% |
| Dec 31, 2021 | 568.84M | -49.47% |
| Dec 31, 2020 | 1.13B | 327.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 885.19B |
| Johnson & Johnson | 466.99B |
| AbbVie | 397.96B |
| UnitedHealth Group | 296.62B |
| AstraZeneca | 275.02B |
| Novartis AG | 249.68B |
| Merck & Co. | 225.74B |
| Abbott Laboratories | 220.84B |